Skip to content
Skip to footer
Home
Solution
Team
News
Contact
Close
Home
Solution
Team
News
Contact
News
Sartar was awarded a U.S. patent
October 16, 2017
Sartar was awarded a U.S. patent for use of anagrelide in cancer therapy.
You May Also Like
News
Sartar’s therapy method featured in Drug Target Review
News
Sartar was chosen among the top 30 innovative life science companies in RESI Innovation Challenge
News
Sartar is hiring a Drug Development Director